We are live on ! Find out more
AMAG

AMAG Pharmaceuticals
AMAG

Delisted

AMAG was delisted on the 13th of November, 2020.

Back to rankings

185 hedge funds and large institutions have $1B invested in AMAG Pharmaceuticals in 2016 Q1 according to their latest regulatory filings, with 44 funds opening new positions, 75 increasing their positions, 43 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

74% more repeat investments, than reductions

Existing positions increased: 75 | Existing positions reduced: 43

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

47% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 30

8% more funds holding

Funds holding: 172 → 185 (+13)

24% less capital invested

Capital invested by funds: $1.32B → $1B (-$311M)

99% less call options, than puts

Call options by funds: $1.82M | Put options by funds: $175M

Holders
185
Holders Change
+13
Holders Change %
+7.56%
% of All Funds
4.93%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.08%
New
44
Increased
75
Reduced
43
Closed
30
Calls
$1.82M
Puts
$175M
Net Calls
-$173M
Net Calls Change
-$172M

Top Buyers

Rank Fund Capital Flow
1
BFA
BlackRock Fund Advisors
California
+$36.3M
2
SIM
Stelliam Investment Management
New York
+$18.6M
3
CCM
Camber Capital Management
Massachusetts
+$14.2M
4
FPC
Falcon Point Capital
California
+$9.04M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$7.94M

Top Sellers

Rank Fund Capital Flow
1
Westfield Capital Management
Westfield Capital Management
Massachusetts
-$31.8M
2
Millennium Management
Millennium Management
New York
-$29.3M
3
PI
Putnam Investments
Massachusetts
-$26.6M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$23.7M
5
PC
PointState Capital
New York
-$12.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
AllianceBernstein
76
AllianceBernstein
Tennessee
$1.3M – – –
IIM
77
Ironwood Investment Management
Massachusetts
$1.29M -$862K -36,303 -40%
Swiss National Bank
78
Swiss National Bank
Switzerland
$1.27M +$282K +11,900 +27%
SEI Investments
79
SEI Investments
Pennsylvania
$1.2M +$40.4K +1,704 +3%
SCM
80
Stevens Capital Management
Pennsylvania
$1.14M +$1.16M +48,719 New
BG
81
BlackRock Group
United Kingdom
$1.13M +$953K +40,173 +503%
CS
82
Credit Suisse
Switzerland
$1.11M +$622K +26,195 +123%
RhumbLine Advisers
83
RhumbLine Advisers
Massachusetts
$1.04M +$168K +7,090 +19%
Balyasny Asset Management
84
Balyasny Asset Management
Illinois
$1M -$9.25M -389,568 -90%
DCM
85
Dialectic Capital Management
Connecticut
$960K +$973K +41,000 New
CCI
86
Credit Capital Investments
New Jersey
$932K +$698K +29,413 +283%
TC
87
TFS Capital
Pennsylvania
$910K +$923K +38,870 New
Comerica Bank
88
Comerica Bank
Texas
$901K +$840K +35,404 New
MERSOM
89
Municipal Employees' Retirement System of Michigan
Michigan
$895K +$908K +38,270 New
BCM
90
Bridgeway Capital Management
Texas
$842K – – –
SO
91
STRS Ohio
Ohio
$823K +$83.1K +3,500 +11%
Barclays
92
Barclays
United Kingdom
$820K +$811K +34,176 +2,274%
RFC
93
Regions Financial Corp
Alabama
$788K -$154K -6,486 -16%
Commonwealth Equity Services
94
Commonwealth Equity Services
Massachusetts
$753K +$50.8K +2,140 +7%
AL
95
Airain Ltd
Guernsey
$753K +$764K +32,195 New
BCM
96
Buckhead Capital Management
Georgia
$722K +$327K +13,781 +81%
ProShare Advisors
97
ProShare Advisors
Maryland
$719K -$52K -2,191 -7%
TPSF
98
Texas Permanent School Fund
Texas
$650K +$659K +27,775 New
State of Tennessee, Department of Treasury
99
State of Tennessee, Department of Treasury
Tennessee
$622K +$631K +26,600 New
AIG
100
American International Group
New York
$613K +$184K +7,743 +42%
2 3
4
5 6

AMAG Hedge Fund Activity: Q1 2016 in Review

185 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in AMAG Pharmaceuticals (AMAG) for Q1 2016, worth a combined $1B — down 24% from $1.32B a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new AMAG positions and 30 closed out — a net gain of 14 holders — while 75 added to existing stakes and 43 trimmed.

The largest buyer was BlackRock Fund Advisors, adding an estimated $36.3M. The largest seller was Westfield Capital Management, cutting an estimated $31.8M.

  • 185 institutional investors held AMAG Pharmaceuticals (AMAG) as of Q1 2016, up from 172 in Q4 2015.
  • Funds reported $1B of AMAG Pharmaceuticals stock for Q1 2016, down 24% quarter-over-quarter.
  • 44 funds opened new AMAG Pharmaceuticals positions in Q1 2016 and 30 closed out, a net change of +14 holders.
  • The largest AMAG Pharmaceuticals buyer in Q1 2016 was BlackRock Fund Advisors, an estimated $36.3M added.
  • The largest AMAG Pharmaceuticals seller in Q1 2016 was Westfield Capital Management, an estimated $31.8M sold.

Based on aggregated 13F filings for Q1 2016.